Phendimetrazine Tartrate 35 mg/1 (Phendimetrazine Tartrate TABLET) 35 mg/1

Phendimetrazine Tartrate 35 mg tablets are an appetite suppressant designed to aid weight management. This oral medication is commonly used as part of a broader weight loss strategy.

Strength

35 mg/1

Pack Size

30 TABLET in 1 BOTTLE (10702-078-03)

Manufacturer / TM Owner

KVK-TECH, INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Phendimetrazine Tartrate is primarily used to help manage obesity by suppressing appetite. It is often prescribed for individuals who need assistance with weight control as part of a comprehensive plan that includes diet and exercise. This medication is intended for short-term use to support weight loss efforts.

Side Effects

Phendimetrazine Tartrate may cause common side effects such as dry mouth, insomnia, and increased heart rate. Some users may also experience dizziness or digestive issues. These effects can vary from person to person.

Precautions & Warnings

It is important to use Phendimetrazine Tartrate as directed by a healthcare professional. This medication should not be taken by individuals with certain medical conditions, such as heart disease or hyperthyroidism. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

Phendimetrazine Tartrate can interact with other medications, including stimulants and certain antidepressants. It is advisable to avoid alcohol while taking this medication, as it may enhance side effects. Always consult a healthcare professional before combining Phendimetrazine Tartrate with other substances.

Frequently Asked Questions

Phendimetrazine Tartrate is used to suppress appetite and aid in weight management as part of a broader weight loss plan.

Phendimetrazine Tartrate is typically taken orally, usually in the morning or before meals, as directed by a healthcare professional.

Common side effects may include dry mouth, insomnia, increased heart rate, dizziness, and digestive issues.

Phendimetrazine Tartrate can interact with other medications, so it is important to consult a healthcare professional before combining it with any other substances.

Phendimetrazine Tartrate is generally intended for short-term use. Long-term use should be discussed with a healthcare professional.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.